This study
aimed to test a novel method of compliance measurement in Portuguese
community pharmacy in Helicobacter pylori patients.
A case series design was used where compliance indicators were
electronically measured, aside with patients’ reports. Experienced
adverse drug reactions, perceived benefit of therapy and quality
of life were also measured.
Mean compliance proportion was 56% and a positive impact on patients’
perceived health status was found. The method used was welcomed
by community pharmacists, albeit having an influence on patients’
normal behaviour.